To provide more evidence for GLI targeting by this compound, BAS 07019774 was also found to be effective in reducing the viability of a GLI-dependent lung cancer cell line SK-MES-1 but was ineffective in a lung cancer line with minimal GLI expression (H1437). The gene discussed is GLI1; the disease is lung carcinoma.